Ieq Capital LLC Acquires Shares of 310,352 Bath & Body Works, Inc. $BBWI

Ieq Capital LLC acquired a new stake in Bath & Body Works, Inc. (NYSE:BBWI) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 310,352 shares of the company’s stock, valued at approximately $7,178,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Global Retirement Partners LLC acquired a new position in Bath & Body Works in the fourth quarter valued at approximately $31,000. Activest Wealth Management acquired a new stake in shares of Bath & Body Works during the 4th quarter worth approximately $32,000. Geneos Wealth Management Inc. grew its stake in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares during the period. Parallel Advisors LLC increased its holdings in shares of Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after purchasing an additional 567 shares in the last quarter. Finally, Danske Bank A S purchased a new position in shares of Bath & Body Works during the 3rd quarter valued at approximately $39,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Trading Up 0.1%

NYSE BBWI opened at $19.47 on Monday. The stock has a fifty day simple moving average of $20.47 and a 200-day simple moving average of $20.08. The stock has a market cap of $3.92 billion, a PE ratio of 5.47, a P/E/G ratio of 1.92 and a beta of 1.38. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $32.32.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.29 by $0.03. The firm had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The business’s revenue for the quarter was down 3.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Research analysts predict that Bath & Body Works, Inc. will post 2.63 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date is Friday, August 21st. Bath & Body Works’s dividend payout ratio is 22.47%.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the stock. JPMorgan Chase & Co. increased their price target on shares of Bath & Body Works from $22.00 to $24.00 and gave the stock a “neutral” rating in a report on Tuesday, August 18th. Jefferies Financial Group upped their price objective on shares of Bath & Body Works from $22.00 to $23.00 and gave the stock a “hold” rating in a research report on Tuesday, July 28th. Telsey Advisory Group lowered their target price on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a research note on Thursday, May 28th. The Goldman Sachs Group lowered Bath & Body Works from a “neutral” rating to a “sell” rating and dropped their price objective for the company from $23.00 to $19.00 in a report on Wednesday, July 8th. Finally, Weiss Ratings raised shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 9th. Four research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $22.57.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.